Title: Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
Abstract:On December 1, the U.S. Food and Drug Administration (FDA) approved 68Ga-PSMA-11 for PET imaging of prostate-specific membrane antigen (PSMA)–positive lesions in men with prostate cancer. It is the fi...On December 1, the U.S. Food and Drug Administration (FDA) approved 68Ga-PSMA-11 for PET imaging of prostate-specific membrane antigen (PSMA)–positive lesions in men with prostate cancer. It is the first approval for a PSMA PET tracer in the United States. The approval was granted to theRead More